Alentis Therapeutics is a thriving clinical-stage biotech company in Basel, Switzerland, developing breakthrough treatments for organ fibrosis and CLDN1 positive tumors. The company, lead by…
Endometriosis is a painful and debilitating condition that affects one in every ten women. Despite being a common health issue, there are currently limited treatment…
What startups need to know about term sheets, legal due diligence and employee incentives Conducting legal due diligence and preparing and negotiating term sheets for…
Building biotech companies and raising venture capital financing In our latest event co-organized with Pureos, we had three extraordinary biotech founders (one of them who…
NXI Therapeutics (formerly Nextimmune), the specialist biotech developing next generation immunosuppressive drugs for autoimmune diseases and organ transplantation, today announces that it has appointed Dr…
Stephan Emmerth, Director Business Development & Operations BaseLaunch and Paul Eschmann, Head of International Markets and Business Affairs Basel Area Business & Innovation, describe the…
Anaveon, a clinical-stage immuno-oncology company, announced updated clinical data from the ongoing Phase I/II study of ANV419 in patients with solid tumors, as well as…